English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
インデックス付き
- 索引コペルニクス
- Google スカラー
- Jゲートを開く
- レフシーク
- ハムダード大学
- エブスコ アリゾナ州
- OCLC-WorldCat
- パブロン
- ユーロパブ
- ICMJE
役立つリンク
オープンアクセスジャーナル
このページをシェアする
抽象的な
Multidrug Resistant Tuberculosis: Still a Problem in the Russian Federation
Dronova Tatiana Alekseyevna, Rodrigo Sardenberg, Sofia Wagemaker Viana, Gabriel Antonio Roberto, Polyakov Dmitry Viktorovich
Objective: Tuberculosis is a primitive disease that is still quite prevalent today. Multidrug resistant tuberculosis is the main cause of death by tuberculosis in Russia. This study aims to present results on tuberculosis and multidrug resistant tuberculosis in Russia.
Methods: A systematic review was conducted to identify studies that investigated multidrug resistant tuberculosis in Russia, using the databases PubMed/NCBI, WHO, Google Scholar, CyberLeninka, XXX National Congress on Respiratory Diseases in Moscow, and Russian Ministry of Health databases from the last five years. Originally 684 studies were recognized in the databases searched, of which 40 articles were selected for the current study.
Results: According to the World Health Organization, Russia was the country with the most tuberculosis cases in the world, although these figures have decreased over the past 21 years. Instead, the cases of multidrug resistant tuberculosis are increasing: 37,357 people in 2015 against 34,832 in 2012.
Conclusion: We observed a high rate of multidrug resistant tuberculosis in Russia due to mistakes such as lack of drugs and low adherence to treatment.